Background: Symptomatic primary Epstein-Barr virus infection is a usually self-limiting illness in adolescents. We present a case of an adolescent who had been receiving azathioprine for inflammatory bowel disease for four years and developed a life-threatening primary Epstein-Barr virus infection successfully treated with rituximab.
Case Presentation: An 11-year-old girl presented with chronic, bloody diarrhea.
Aim: This study investigated oral immunotherapy (OIT) for children aged 6-18 years with wheat allergies.
Methods: Well-cooked wheat spaghetti was given to 100 children with wheat allergies every day for 17 weeks, increasing from 0.3 to 2000 mg of wheat protein, followed by three- and nine-month maintenance phases.
Objective: To investigate the incidence of cow's milk allergy as evidenced by milk challenge and the findings of endoscopic and immunohistochemical examinations in children with chronic and refractory constipation.
Study Design: Thirty-five study subjects (mean age, 8.3 +/- 3.